Svein Solheim

  • MD PhD
  • +47 2211 9100
Fax: +47 2211 9181
 

Publications 2019

Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2019)
Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population
Atherosclerosis, 286, 53-59 (in press)
DOI 10.1016/j.atherosclerosis.2019.05.004, PubMed 31100620

Bratseth V, Chiva-Blanch G, Byrkjeland R, Solheim S, Arnesen H, Seljeflot I (2019)
Elevated levels of circulating microvesicles in coronary artery disease patients with type 2 diabetes and albuminuria: Effects of exercise training
Diab Vasc Dis Res, 1479164119843094 (in press)
DOI 10.1177/1479164119843094, PubMed 31023084

Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I (2019)
High Adherence to the Nordic Diet Is Associated with Lower Levels of Total and Platelet-Derived Circulating Microvesicles in a Norwegian Population
Nutrients, 11 (5)
DOI 10.3390/nu11051114, PubMed 31109111

Holte KB, Svanteson M, Hanssen KF, Haig Y, Solheim S, Berg TJ (2019)
Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study
J Diabetes Complications, 33 (5), 383-389
DOI 10.1016/j.jdiacomp.2019.01.006, PubMed 30846232

Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2019)
Effects of exercise training on inflammasome-related mediators and their associations to glucometabolic variables in patients with combined coronary artery disease and type 2 diabetes mellitus: Sub-study of a randomized control trial
Diab Vasc Dis Res, 1479164119836922 (in press)
DOI 10.1177/1479164119836922, PubMed 30939905

Publications 2018

Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2018)
Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study
Diabetol Metab Syndr, 10, 59
DOI 10.1186/s13098-018-0360-3, PubMed 30038669

Danielsen SO, Moons P, Sandven I, Leegaard M, Solheim S, Tønnessen T, Lie I (2018)
Thirty-day readmissions in surgical and transcatheter aortic valve replacement: A systematic review and meta-analysis
Int J Cardiol, 268, 85-91
DOI 10.1016/j.ijcard.2018.05.026, PubMed 29779575

Langseth MS, Opstad TB, Bratseth V, Solheim S, Arnesen H, Pettersen AÅ, Seljeflot I, Helseth R (2018)
Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease
Eur J Prev Cardiol, 25 (7), 762-769
DOI 10.1177/2047487318760618, PubMed 29473463

Wieckowska-Luth M, Solheim S, Schulke A, Kirleis W (2018)
Towards a refined understanding of the use of coastal zones in the Mesolithic: New investigations on human-environment interactions in Telemark, southeastern Norway
J. Archaeol. Sci.-Rep., 17, 839-851

Publications 2017

Bratseth V, Byrkjeland R, Njerve IU, Solheim S, Arnesen H, Seljeflot I (2017)
Procoagulant activity in patients with combined type 2 diabetes and coronary artery disease: No effects of long-term exercise training
Diab Vasc Dis Res, 14 (2), 144-151
DOI 10.1177/1479164116679080, PubMed 28111966

Byrkjeland R, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2017)
Reduced endothelial activation after exercise is associated with improved HbA1c in patients with type 2 diabetes and coronary artery disease
Diab Vasc Dis Res, 14 (2), 94-103
DOI 10.1177/1479164116679077, PubMed 28111980

Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I (2017)
Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity
PLoS One, 12 (2), e0172558
DOI 10.1371/journal.pone.0172558, PubMed 28207887

Lie I, Danielsen SO, Tønnessen T, Solheim S, Leegaard M, Sandvik L, Wisløff T, Vangen J, Røsstad TH, Moons P (2017)
Determining the impact of 24/7 phone support on hospital readmissions after aortic valve replacement surgery (the AVRre study): study protocol for a randomised controlled trial
Trials, 18 (1), 246
DOI 10.1186/s13063-017-1971-y, PubMed 28693599

Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Norseth J, Arnesen H, Solheim S (2017)
Galectin-3, a marker of cardiac remodeling, is inversely related to serum levels of marine omega-3 fatty acids. A cross-sectional study
JRSM Cardiovasc Dis, 6, 2048004017729984
DOI 10.1177/2048004017729984, PubMed 28932392

Njerve IU, Åkra S, Weiss TW, Solheim S, Øvstebø R, Aass HCD, Byrkjeland R, Arnesen H, Seljeflot I (2017)
A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease
Mediators Inflamm, 2017, 5380638
DOI 10.1155/2017/5380638, PubMed 28596642

Publications 2016

Byrkjeland R, Stensæth KH, Anderssen S, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2016)
Effects of exercise training on carotid intima-media thickness in patients with type 2 diabetes and coronary artery disease. Influence of carotid plaques
Cardiovasc Diabetol, 15, 13
DOI 10.1186/s12933-016-0336-2, PubMed 26801098

Helseth R, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2016)
The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris
Mediators Inflamm, 2016, 2182358
DOI 10.1155/2016/2182358, PubMed 28074081

Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Arnesen H, Solheim S (2016)
Serum Fatty Acids, Traditional Risk Factors, and Comorbidity as Related to Myocardial Injury in an Elderly Population with Acute Myocardial Infarction
J Lipids, 2016, 4945720
DOI 10.1155/2016/4945720, PubMed 26989512

Myhre PL, Laake K, Seljeflot I, Solheim S, Arnesen H (2016)
[Clinical research on elderly]
Tidsskr Nor Laegeforen, 136 (3), 208
DOI 10.4045/tidsskr.15.1300, PubMed 26860377

Njerve IU, Byrkjeland R, Arnesen H, Åkra S, Solheim S, Seljeflot I (2016)
Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial
Diabetes Metab Syndr Obes, 9, 55-62
DOI 10.2147/DMSO.S96299, PubMed 27042130

Publications 2015

Byrkjeland R, Njerve IU, Anderssen S, Arnesen H, Seljeflot I, Solheim S (2015)
Effects of exercise training on HbA1c and VO2peak in patients with type 2 diabetes and coronary artery disease: A randomised clinical trial
Diab Vasc Dis Res, 12 (5), 325-33
DOI 10.1177/1479164115590552, PubMed 26092822

Dudek D, Siudak Z, Solheim S (2015)
New model of secondary cardiovascular prevention for patients after acute coronary syndromes in Poland with regard to Norwegian experiences
Kardiol Pol, 74 (2), 101-3
DOI 10.5603/KP.a2015.0176, PubMed 26365935

Helseth R, Opstad T, Solheim S, Lunde K, Arnesen H, Seljeflot I (2015)
The Effect of Intracoronary Stem Cell Injection on Markers of Leukocyte Activation in Acute Myocardial Infarction
Cardiol Res, 6 (1), 209-215
DOI 10.14740/cr375w, PubMed 28197227

Helseth R, Weiss TW, Opstad TB, Siegbahn A, Solheim S, Freynhofer MK, Huber K, Arnesen H, Seljeflot S (2015)
Associations between circulating proteins and corresponding genes expressed in coronary thrombi in patients with acute myocardial infarction
Thromb Res, 136 (6), 1240-4
DOI 10.1016/j.thromres.2015.10.005, PubMed 26475405

Laake K, Seljeflot I, Fagerland MW, Njerve IU, Arnesen H, Solheim S (2015)
Effects on serum fractalkine by diet and omega-3 fatty acid intervention: relation to clinical outcome
Mediators Inflamm, 2015, 373070
DOI 10.1155/2015/373070, PubMed 25733777

Publications 2014

Byrkjeland R, Edvardsen E, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2014)
Insulin levels and HOMA index are associated with exercise capacity in patients with type 2 diabetes and coronary artery disease
Diabetol Metab Syndr, 6 (1), 36
DOI 10.1186/1758-5996-6-36, PubMed 24612649

Furenes EB, Opstad TB, Solheim S, Lunde K, Arnesen H, Seljeflot I (2014)
The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction
Mediators Inflamm, 2014, 385901
DOI 10.1155/2014/385901, PubMed 25294955

Helseth R, Seljeflot I, Opstad T, Solheim S, Freynhofer M, Arnesen H, Huber K, Weiss T (2014)
Genes expressed in coronary thrombi are associated with ischemic time in patients with acute myocardial infarction
Thromb Res, 135 (2), 329-33
DOI 10.1016/j.thromres.2014.11.028, PubMed 25496999

Helseth R, Solheim S, Opstad T, Hoffmann P, Arnesen H, Seljeflot I (2014)
The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention
Mediators Inflamm, 2014, 608414
DOI 10.1155/2014/608414, PubMed 24737925

Laake K, Myhre P, Nordby LM, Seljeflot I, Abdelnoor M, Smith P, Tveit A, Arnesen H, Solheim S (2014)
Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study
BMC Geriatr, 14, 74
DOI 10.1186/1471-2318-14-74, PubMed 24928284

Njerve IU, Solheim S, Lunde K, Hoffmann P, Arnesen H, Seljeflot I (2014)
Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction; no influence of autologous bone marrow derived stem cell injection
Cytokine, 69 (1), 131-5
DOI 10.1016/j.cyto.2014.05.022, PubMed 24930044

Publications 2013

Hopp E, Bjørnerud A, Lunde K, Solheim S, Aakhus S, Arnesen H, Forfang K, Edvardsen T, Smith HJ (2013)
Perfusion MRI at rest in subacute and chronic myocardial infarct
Acta Radiol, 54 (4), 401-11
DOI 10.1177/0284185113475605, PubMed 23401603

Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2013)
Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
Thromb J, 11 (1), 1
DOI 10.1186/1477-9560-11-1, PubMed 23311309

Publications 2012

Bliksøen M, Mariero LH, Ohm IK, Haugen F, Yndestad A, Solheim S, Seljeflot I, Ranheim T, Andersen GØ, Aukrust P, Valen G, Vinge LE (2012)
Increased circulating mitochondrial DNA after myocardial infarction
Int J Cardiol, 158 (1), 132-4
DOI 10.1016/j.ijcard.2012.04.047, PubMed 22578950

Publications 2011

Grøgaard HK, Solheim S, Landsverk KS, Seljeflot I, Hoffmann P, Arnesen H, Ilebekk A (2011)
Circulating CD34⁺ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris
Scand J Clin Lab Invest, 71 (4), 322-9
DOI 10.3109/00365513.2011.565367, PubMed 21463159

Hopp E, Lunde K, Solheim S, Aakhus S, Arnesen H, Forfang K, Edvardsen T, Smith HJ (2011)
Regional myocardial function after intracoronary bone marrow cell injection in reperfused anterior wall infarction - a cardiovascular magnetic resonance tagging study
J Cardiovasc Magn Reson, 13, 22
DOI 10.1186/1532-429X-13-22, PubMed 21414223

Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2011)
The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction
Thromb Res, 130 (5), 765-8
DOI 10.1016/j.thromres.2011.11.045, PubMed 22192151

Publications 2010

Beitnes JO, Gjesdal O, Lunde K, Solheim S, Edvardsen T, Arnesen H, Forfang K, Aakhus S (2010)
Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study
Eur J Echocardiogr, 12 (2), 98-106
DOI 10.1093/ejechocard/jeq116, PubMed 20851818

Grøgaard HK, Seljeflot I, Lunde K, Solheim S, Aakhus S, Forfang K, Arnesen H, Ilebekk A (2010)
Cell treatment after acute myocardial infarction prevents early decline in circulating IGF-1
Scand Cardiovasc J, 44 (5), 267-72
DOI 10.3109/14017431.2010.490949, PubMed 21080844

Solheim S, Seljeflot I, Lunde K, Bjørnerheim R, Aakhus S, Forfang K, Arnesen H (2010)
Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy
Am J Cardiol, 106 (9), 1197-200
DOI 10.1016/j.amjcard.2010.06.043, PubMed 21029812

Sverdrup Ø, Jensen T, Solheim S, Gjesdal K (2010)
Training auscultatory skills: computer simulated heart sounds or additional bedside training? A randomized trial on third-year medical students
BMC Med Educ, 10, 3
DOI 10.1186/1472-6920-10-3, PubMed 20082701

Weiss TW, Furenes EB, Trøseid M, Solheim S, Hjerkinn EM, Seljeflot I, Arnesen H (2010)
Prediction of cardiovascular events by matrix metalloproteinase (MMP)-9 in elderly men
Thromb Haemost, 103 (3), 679-81
DOI 10.1160/TH09-05-0317, PubMed 20076844

Publications 2009

Beitnes JO, Hopp E, Lunde K, Solheim S, Arnesen H, Brinchmann JE, Forfang K, Aakhus S (2009)
Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study
Heart, 95 (24), 1983-9
DOI 10.1136/hrt.2009.178913, PubMed 19833610

Furenes EB, Arnesen H, Solheim S, Grøgaard HK, Hoffmann P, Seljeflot I (2009)
The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina
Thromb Res, 124 (5), 560-4
DOI 10.1016/j.thromres.2009.04.001, PubMed 19410278

Taraldsrud E, Grøgaard HK, Solheim S, Lunde K, Fløisand Y, Arnesen H, Seljeflot I, Egeland T (2009)
Age and stress related phenotypical changes in bone marrow CD34+ cells
Scand J Clin Lab Invest, 69 (1), 79-84
DOI 10.1080/00365510802419447, PubMed 18836945

Publications 2008

Christensen AH, Ribic D, Solheim S, Gjesdal K (2008)
[Occurrence of arrhythmias related to treatment of myocardial infarction]
Tidsskr Nor Laegeforen, 128 (19), 2163-6
PubMed 18846137

Furenes EB, Seljeflot I, Solheim S, Hjerkinn EM, Arnesen H (2008)
Long-term influence of diet and/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein-A in men at high risk of coronary heart disease
Scand J Clin Lab Invest, 68 (3), 177-84
DOI 10.1080/00365510701663350, PubMed 17934973

Lunde K, Solheim S, Forfang K, Arnesen H, Brinch L, Bjørnerheim R, Ragnarsson A, Egeland T, Endresen K, Ilebekk A, Mangschau A, Aakhus S (2008)
Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up
J Am Coll Cardiol, 51 (6), 674-6
DOI 10.1016/j.jacc.2007.10.032, PubMed 18261689

Solheim S, Grøgaard HK, Hoffmann P, Arnesen H, Seljeflot I (2008)
Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris
Scand J Clin Lab Invest, 68 (7), 555-62
DOI 10.1080/00365510701884584, PubMed 19378426

Solheim S, Seljeflot I, Lunde K, Aukrust P, Yndestad A, Grøgaard HK, Aakhus S, Forfang K, Arnesen H (2008)
Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction
Am Heart J, 155 (1), 55.e1-9
DOI 10.1016/j.ahj.2007.10.005, PubMed 18082489

Publications 2007

Lunde K, Solheim S, Aakhus S, Arnesen H, Moum T, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Forfang K (2007)
Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial
Am Heart J, 154 (4), 710.e1-8
DOI 10.1016/j.ahj.2007.07.003, PubMed 17892996

Publications 2006

Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grøgaard HK, Bjørnerheim R, Brekke M, Müller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K (2006)
Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction
N Engl J Med, 355 (12), 1199-209
DOI 10.1056/NEJMoa055706, PubMed 16990383

Solheim S, Pettersen AA, Arnesen H, Seljeflot I (2006)
No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease
Thromb Haemost, 96 (5), 660-4
DOI 10.1160/TH06-06-0337, PubMed 17080224

Publications 2005

Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Forfang K, ASTAMI investigators (2005)
Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects
Scand Cardiovasc J, 39 (3), 150-8
DOI 10.1080/14017430510009131, PubMed 16152682

Publications 2004

Seljeflot I, Hurlen M, Solheim S, Arnesen H (2004)
Serum levels of interleukin-10 are inversely related to future events in patients with acute myocardial infarction
J Thromb Haemost, 2 (2), 350-2
DOI 10.1111/j.1538-7933.2004.0584c.x, PubMed 14996010

Publications 2003

Solheim S, Arnesen H, Eikvar L, Hurlen M, Seljeflot I (2003)
Influence of aspirin on inflammatory markers in patients after acute myocardial infarction
Am J Cardiol, 92 (7), 843-5
DOI 10.1016/S0002-9149(03)00897-X, PubMed 14516890

Publications 2001

Solheim S, Seljeflot I, Arnesen H, Eritsland J, Eikvar L (2001)
Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks
Atherosclerosis, 157 (2), 411-5
DOI 10.1016/S0021-9150(00)00725-5, PubMed 11472741

Publications 2000

Langberg CW, Solheim S, Hagen S (2000)
[Can radiotherapy reduce the frequency of restenosis after coronary angioplasty?]
Tidsskr Nor Laegeforen, 120 (6), 707-10
PubMed 10806885

Page visits: 2538